NMTC vs REG · rev $3.5M vs P/E 34, $12.93B cap
Neuroone Medical Technologies Corp (NMTC) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Neuroone Medical Technologies Corp (NMTC) is a medical devices company listed on US.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported NMTC revenue for 2024-09-30 was $3.5M. Net income was -$12.3M. Revenue was up 76.9% from 2023-09-30 to 2024-09-30. NMTC currently screens at market cap $35.5M.
REG does not have a complete income-statement cache yet.
NMTC currently screens at market cap $35.5M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the NMTC and REG stock pages for the full models.
Not investment advice.